Prescription drug abuse remains a huge problem. One way healthcare workers and law enforcement hope to reduce the problem is by using electronic prescriptions for controlled substances, which helps physicians, pharmacists, and law enforcement officials to track dispensing.
More than 500 CEOs of hospitals and health systems urged Congress to protect the 340B drug pricing program, which helps fund free and low-cost medication access and clinics for the underserved.
The leaders of at least one county in California believe so. The Santa Clara Board of Supervisors recently approved an ordinance that will require pharmaceutical companies to design, operate, and fund a program to safely dispose of residents’ unwanted drugs.
A new formulation of peppermint oil has been shown to relieve severe IBS symptoms in adults.
The new independent company, Option Care, sees opportunity for growth in the $14 billion alternate site infusion market.
Looking for that first pharmacy job? Here are a few things to keep in mind.
Walgreens recently opened a retail pharmacy inside Our Lady of Lourdes Medical Center in Camden, N.J.
CVS Health has agreed to pay a $22 million penalty following an investigation by the U.S. Drug Enforcement Administration that found two of the chain’s Florida pharmacies had dispensed controlled substances without legitimate prescriptions.
The Virginia State Board of pharmacy has temporarily closed a Richmond pharmacy from which more than 50,000 controlled substances were stolen during a two-year period, including oxycodone, hydrocodone, and methadone.
When it comes to using plain language, clearly displaying content, and engaging users, paid mobile applications for managing diabetes are more useful than free ones, according to a study published by the Centers for Disease Control and Prevention.
The good news is that the five-year relative survival rates for major cancers are rising. The bad news is that patient out-of-pocket costs associated with IV cancer drugs have also increased as physician-owned practices have been purchased by hospitals, according to a recent report from IMS Institute for Healthcare Informatics.
Letters, e-mails, comments, and posts by Drug Topics readers
Alternatives for those who sneeze in the spring.
New Rx approvals, new launches, new indications, new formulation, new dosage strengths, new biosimilar, new generics, new OTC
Under universal healthcare, no U.S. resident will be denied healthcare services. And the chief service deniers - and payment refusers - will be restructured or gone.
How many good managers have you had? Same for Mike Lahr. In this article, he tells you why.
Only indy pharmacies have it, and it may make all the difference.
Medication adherence counseling is something pharmacists do best. Evolving paradigms in healthcare delivery will resolve how they will be paid for it.
Nothing rings truer than the voice of experience. Four pharmacists share what works for them.
When pharmacists achieve provider status, patients will benefit, payers will save on costs, and providers will get an assist. So what's holding things up?
A pharmacist with good communication skills can turn indifferent compliance into successful patient outcomes.
Pharmacists are now being included in care teams wherever outcomes are being tracked. Provider status is only a matter of time.
Maine was only the first skirmish. Now the battle to import drugs from Canada has moved to Capitol Hill.
Last December, FDA granted accelerated approval to nivolumab for treatment of unresectable or metastatic melanoma in patients with cancer that no longer responds to other therapies.
Some tips on what constitutes a QA and how to comply with pharmacy law when creating one.
Here's what a concerned corporation might do to support employee empowerment and reward loyalty to the company.
Adding pharmacists to the care team will result in better patient outcomes, lower payer costs, relief for physicians, and better use of pharmacists' skills and experience. It's a no-brainer.
Secondary prevention of MI still calls for a careful balancing act between risks and benefits.
A coalition of pharmaceutical companies has formed the Biosimilars Forum, a nonprofit seeking to expand patient access to biosimilars in the United States.
The National Community Pharmacists Association (NCPA) has endorsed legislation that would expand the number of pharmacies that could offer discounted copays for Medicare Part D prescription drugs.